Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 02:12 IST
Shilpa Medicare gets EIR for both API facilities at Raichur
Source: IRIS | 11 Jul, 2018, 12.02PM
Comments  |  Post Comment

Shilpa Medicare has received EIR (Establishment Inspection Report) from USFDA to its two API manufacturing facilities located at Raichur, Karnataka.

The inspection was carried out between January 16-19, 2018. The inspection has now been closed by USFDA, which means that both the facilities have now clearance from the USFDA.

The stock had underperformed the market over the past one month till Jul. 10, 2018, falling 3.04% compared with the Sensex's 2.60% rise. It underperformed the market in past one quarter, declining 18.18% as against 6.96% rise in the Sensex.

Shares of the company gained Rs 34.35, or 8.82%, to trade at Rs 424.00. The total volume of shares traded was 56,094 at the BSE (11.48 a.m., Wednesday).





Shilpa Medicare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Fortis accepts Rs 40 bn investment offer from IHH Healthcare Berhad - 13-Jul-2018 10:38
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
Lupin receives nod for generic Nitrofurantoin capsules - 12-Jul-2018 12:39
Aban Offshore receives LoA for deployment of 3 jack-up rigs in UAE - 12-Jul-2018 12:26
Sun Pharma arm Dusa files lawsuit against Biofrontera - 12-Jul-2018 11:01
Larsen & Tubro wins orders worth Rs 23.88 bn - 12-Jul-2018 10:51
Alembic Pharma receives USFDA tentative approval for lloperidone Tablets - 12-Jul-2018 10:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer